EPI (HOLDINGS) (00689) granted a loan facility of NZD 3 million.

19:48 19/03/2026

Chang Ying Group (Holdings) (00689) announced that on March 19, 2026 (after the trading session), the lender EPI ESG Investment (New Zealand) Limited (an indirect wholly-owned subsidiary of the Company in New Zealand) entered into a loan agreement with Swiftriver Limited (borrower, mortgagor) and guarantor. Under this agreement, the lender has agreed to provide a loan amount of NZ$3 million (approximately HK$13.5 million) to the borrower, with a repayment period of six months.

EPI (HOLDINGS) (00689) announced that on March 19, 2026 (after trading hours), the lender EPI ESG Investment (New Zealand) Limited (an indirect wholly-owned subsidiary of the Company) entered into a loan agreement with Swiftriver Limited (borrower, mortgagor) and guarantor. Under this agreement, the lender agreed to provide a loan amount of NZ$3 million (approximately HK$13.5 million) to the borrower, with a repayment term of six months.

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.

CHINA HONGBAO(08316): Liu Huiqing appointed as independent non-executive director.

CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

Hong Kong-listed AI medical stock buys back the first share! YIDU TECH (02158) repurchased nearly 15 million Hong Kong dollars on March 19, deepening regional layout with Guangxi Medical University.